Concentrix (NASDAQ:CNXC) Price Target Lowered to $84.00 at Barrington Research

Concentrix (NASDAQ:CNXCFree Report) had its target price reduced by Barrington Research from $121.00 to $84.00 in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have an outperform rating on the stock.

Concentrix Trading Up 4.8 %

NASDAQ:CNXC opened at $65.20 on Wednesday. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 1.19. Concentrix has a twelve month low of $59.23 and a twelve month high of $125.80. The company has a market cap of $4.32 billion, a P/E ratio of 11.30, a price-to-earnings-growth ratio of 0.66 and a beta of 0.50. The business has a 50 day moving average price of $78.34 and a two-hundred day moving average price of $83.61.

Concentrix (NASDAQ:CNXCGet Free Report) last released its earnings results on Wednesday, January 24th. The company reported $3.07 earnings per share for the quarter, beating analysts’ consensus estimates of $2.92 by $0.15. The business had revenue of $2.23 billion during the quarter, compared to the consensus estimate of $2.20 billion. Concentrix had a net margin of 4.41% and a return on equity of 18.31%. As a group, analysts expect that Concentrix will post 11.26 EPS for the current fiscal year.

Concentrix Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Stockholders of record on Monday, February 5th were paid a dividend of $0.3025 per share. The ex-dividend date was Friday, February 2nd. This represents a $1.21 annualized dividend and a dividend yield of 1.86%. Concentrix’s dividend payout ratio is currently 20.97%.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Cambridge Investment Research Advisors Inc. boosted its stake in Concentrix by 7.7% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 1,859 shares of the company’s stock valued at $310,000 after buying an additional 133 shares in the last quarter. BlackRock Inc. boosted its holdings in Concentrix by 1.0% in the first quarter. BlackRock Inc. now owns 3,668,975 shares of the company’s stock valued at $611,103,000 after acquiring an additional 35,619 shares during the last quarter. Great West Life Assurance Co. Can raised its stake in Concentrix by 8.0% during the first quarter. Great West Life Assurance Co. Can now owns 23,644 shares of the company’s stock worth $4,049,000 after buying an additional 1,761 shares during the last quarter. Sei Investments Co. raised its position in shares of Concentrix by 168.7% in the 1st quarter. Sei Investments Co. now owns 22,904 shares of the company’s stock worth $3,823,000 after acquiring an additional 14,380 shares in the last quarter. Finally, Aviva PLC acquired a new position in Concentrix in the first quarter valued at approximately $593,000. Institutional investors and hedge funds own 90.34% of the company’s stock.

Concentrix Company Profile

(Get Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Recommended Stories

Analyst Recommendations for Concentrix (NASDAQ:CNXC)

Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.